Heloisa Helena Milioli
Title
Cited by
Cited by
Year
Basal-like breast cancer: molecular profiles, clinical features and survival outcomes
HH Milioli, I Tishchenko, C Riveros, R Berretta, P Moscato
BMC medical genomics 10 (1), 1-17, 2017
462017
The discovery of novel biomarkers improves breast cancer intrinsic subtype prediction and reconciles the labels in the metabric data set
HH Milioli, R Vimieiro, C Riveros, I Tishchenko, R Berretta, P Moscato
PLoS One 10 (7), e0129711, 2015
302015
Comparative proteomics of primary breast carcinomas and lymph node metastases outlining markers of tumor invasion
HH Milioli, KS Sousa, R Kaviski, NCDS Oliveira, CDA Urban, RS De Lima, ...
Cancer Genomics-Proteomics 12 (2), 89-101, 2015
212015
Extensive transcriptomic and genomic analysis provides new insights about luminal breast cancers
I Tishchenko, HH Milioli, C Riveros, P Moscato
PloS one 11 (6), e0158259, 2016
162016
Iteratively refining breast cancer intrinsic subtypes in the METABRIC dataset
HH Milioli, R Vimieiro, I Tishchenko, C Riveros, R Berretta, P Moscato
BioData mining 9 (1), 1-8, 2016
142016
Non-canonical AR activity facilitates endocrine resistance in breast cancer
KM Chia, H Milioli, N Portman, G Laven-Law, R Coulson, A Yong, ...
Endocrine-related cancer 26 (2), 251-264, 2019
82019
Comparative proteomic analysis of ductal and lobular invasive breast carcinoma
NC Oliveira, TH Gomig, HH Milioli, F Cordeiro, GG Costa, CA Urban, ...
Genet Mol Res 15 (2), 1-10, 2016
82016
Cyclin E1 and cyclin E2 in ER+ breast cancer: prospects as biomarkers and therapeutic targets
HH Milioli, S Alexandrou, E Lim, CE Caldon
Endocrine-related cancer 27 (5), R93-R112, 2020
42020
The Androgen Receptor is a Tumor Suppressor in Estrogen Receptor Positive Breast Cancer
Nature Medicine, 1-11, 2021
3*2021
The Androgen Receptor is a Tumour Suppressor in Estrogen Receptor Positive Breast Cancer
W Tilley, T Hickey, L Selth, KM Chia, H Milioli, G Laven-Law, D Roden, ...
10.21203/rs.3.rs-62718/v1, 2020
32020
MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer
N Portman, HH Milioli, S Alexandrou, R Coulson, A Yong, KJ Fernandez, ...
Breast Cancer Research 22 (1), 1-17, 2020
22020
Abstract GS2-03: The androgen receptor is a tumour suppressor in estrogen receptor positive breast cancer
E Lim, TA Hickey, LA Selth, KM Chia, HH Milioli, D Roden, G Laven-Law, ...
Cancer Research 80 (4 Supplement), GS2-03-GS2-03, 2020
12020
Abstract P40: Breast cancer molecular portraits of intrinsic subtypes and integrative clusters in the metabric data set
HH Milioli, C Sanhueza, R Berretta, P Moscato
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 12, 27-27, 2016
12016
Exploring representation: A semiotic approach to understanding the image as a carrier of design meaning in a collective design context.
D Phare
PhD diss., University of Newcastle, 2016
12016
Abstract PS18-17: Mdm2 inhibition synergises with endocrine therapy or cdk4/6 inhibition for the treatment of estrogen receptor-positive breast cancer
N Portman, H Milioli, S Alexandrou, R Coulson, A Yong, K Fernandez, ...
Cancer Research 81 (4 Supplement), PS18-17-PS18-17, 2021
2021
Mdm2 inhibition synergises with endocrine therapy or cdk4/6 inhibition for the treatment of estrogen receptor-positive breast cancer
N Portman, H Milioli, S Alexandrou, R Coulson, A Yong, K Fernandez, ...
CANCER RESEARCH 81 (4), 2021
2021
Differential kynurenine pathway metabolism in highly metastatic aggressive breast cancer subtypes: beyond IDO1-induced immunosuppression
B Heng, AA Bilgin, DB Lovejoy, VX Tan, HH Milioli, L Gluch, ...
Breast Cancer Research 22 (1), 1-14, 2020
2020
OR05-06 The Androgen Receptor Is a Tumour Suppressor in Estrogen Receptor Positive Breast Cancer
TE Hickey, L Selth, KM Chia, H Milioli, D Roden, G Laven-Law, S Jindal, ...
Journal of the Endocrine Society 4 (Supplement_1), OR05-06, 2020
2020
Abstract P4-14-13: Concurrent exercise and chemotherapy in preclinical breast cancer models
S Wahlroos, A Wilkinson, H Milioli, N Portman, D Gallego-Ortega, E Lim
Cancer Research 80 (4 Supplement), P4-14-13, 2020
2020
Abstract P012: Targeting AR in endocrine-resistant breast cancer
KM Chia, H Milioli, N Portman, G Laven-Law, R Coulson, A Yong, ...
7th International Pacific Rim (PacRim) Breast and Prostate Cancer Meeting 1, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20